The U.S. Department of Health and Human Services has released a plan to overhaul the nation's organ transplant system, which has long been plagued by sometimes lethal delays and IT failures.
The plan will open the Organ Procurement and Transplantation Network (OPTN) to competitive bidding, with the goal of upgrading the system to meet industry-leading standards designed to improve data-tracking and how organs are matched with patients.
“Every day, patients and families across the United States rely on the Organ Procurement and Transplantation Network to save the lives of their loved ones who experience organ failure,” said Carole Johnson, HRSA Administrator, in a news release.
The overhaul follows a series of reports from the National Academies of Sciences, Engineering, and Medicine and the White House's U.S. Digital Service that showed widespread failures in the system.
“At HRSA, our stewardship and oversight of this vital work is a top priority," Johnson said. "That is why we are taking action to both bring greater transparency to the system and to reform and modernize the OPTN. The individuals and families that depend on this life-saving work deserve no less.”
High-speed connectivity solutions provider Credo went public on the Nasdaq on Thursday, raising $200 million in its IPO. CEO Bill Brennan, joined Cheddar to discuss its entry into the capital markets and the next chapter for the company. "We're going to be focused on what we have been focused on, which is really creating, creating innovative connectivity solutions that really pushed the edge on efficient power as well as very effective cost," he said.
BD Veritor is a variation of the at-home COVID test that uses a smartphone to interpret the results. The test is taken via a nose swab test strip that is then scanned by your phone’s camera with the result clearly displayed as positive or negative. James Walker, vice president of integrated diagnostics USA for BD, joined Cheddar to discuss how the test hopefully takes the "guesswork out of testing." Walker also went into what BD is doing to deal with the surging demand for at-home tests amid the omicron spread. "While we don't disclose how much we produce, we have capacity to manufacture up to 12 million rapid antigen tests per month and are delivering on our commitments to distributors and retailers," he said.
Low-code app development platform Crowdbotics raised $22 million in a Series A funding round led by Jackson Square Ventures. Crowdbotics has helped more than 14,000 customers launch apps without having to learn how to code. The company can offer a team of expert developers to help companies launch custom apps, or provide the means for companies to develop apps themselves. Crowdbotics CEO Anand Kulkarni joined Cheddar News' Closing Bell to discuss.
Nathan Harding, CEO of Luum, joins Cheddar Innovates to discuss the process of having a robot put on eyelash extensions, and how automation is making its way into the beauty industry
Kevin Yu, Founder and CEO of Sidechef, joins Cheddar Innovates to discuss how it's building a platform to make recipe shopping easy, and how its features help you discover new recipes with the same ingredients to fight the massive problem of food waste.
On this episode of Cheddar Innovates: Sidechef CEO breaks down how it's building a platform to make recipe shopping easy; Luum CEO explains the process of having a robot put on eyelash extensions; A look at Curiosity Stream's new original series, 'Evolve.'
